MICROTECH MED-B(02235) spent approximately HK$281,000 to buy back 38,000 shares on January 30th.
Weitian Medical-B (02235) announced the repurchase of 38,000 shares at a cost of approximately HK$281,000 on January 30, 2026.
MICROTECH MED-B (02235) announced on January 30, 2026 that it will spend about HK$281,000 to repurchase 38,000 shares.
Related Articles
CC Securities (01375) announced a joyous profit forecast, expecting a full-year net profit attributable to shareholders of 4 billion to 4.8 billion, representing a year-on-year increase of 62.70% to 95.24%.
OpenAI discusses listing in Q4 with banks, executives are worried about competitors Anthropic going public first.
ACME INTL HLDGS (01870) issued a profit warning, expecting a net loss of no less than 52 million Hong Kong dollars for the fiscal year 2025.
CC Securities (01375) announced a joyous profit forecast, expecting a full-year net profit attributable to shareholders of 4 billion to 4.8 billion, representing a year-on-year increase of 62.70% to 95.24%.
OpenAI discusses listing in Q4 with banks, executives are worried about competitors Anthropic going public first.
ACME INTL HLDGS (01870) issued a profit warning, expecting a net loss of no less than 52 million Hong Kong dollars for the fiscal year 2025.
RECOMMEND
Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026
Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026
2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026
